Ketanserin

DB12465InvestigationalSmall molecule

Ketanserin has been investigated for the treatment of Septic Shock, Severe Sepsis, and Diabetic Foot Ulcer.

Chemical structure of Ketanserin
Formula / weight
C22H22FN3O3 · 395.434 g/mol (avg)
Code names
R-41,468

Resolves to

Compound
UNII97F9DE4CT4CAS74050-98-9ChEMBLCHEMBL51ChEBI6123PubChem3822KEGGC07464
Clinical / RWD
RxNorm6131ATCC02KD01
Structure
InChIKeyFPCCSQOGAWCVBH-UHFFFAOYSA-NSMILESFC1=CC=C(C=C1)C(=O)C1CCN(CCN2C(=O)NC3=CC=CC=C3C2=O)CC1
Targets
P28223HTR2A

What you can answer from here — as of February 21, 2021

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
1,375Drug interactionsStructured to mechanism, not free text
Sign in
8Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Marketed productsAcross 1 country and 3 labellers
Sign in
1ATC codeIncluding every combination product, plus 14 drug categories
Sign in
5+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Ketanserin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In